TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

This study has been terminated.

( Drug company withdrawal of support for investigational agent in this indication. )

Study NCT00074334 Information provided by Pediatric Brain Tumor Consortium

First Received: December 10, 2003 Last Updated: October 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2006
Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)